KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Tax ProvisionsTax Rate
Others
Ratios

BioNTech SE (BNTX) Revenue (2018 - 2025)

Historic Revenue for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $1.8 billion.

  • BioNTech SE's Revenue rose 2988.99% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 billion, marking a year-over-year increase of 709.01%. This contributed to the annual value of $2.9 billion for FY2024, which is 2845.46% down from last year.
  • Latest data reveals that BioNTech SE reported Revenue of $1.8 billion as of Q3 2025, which was up 2988.99% from $295.2 million recorded in Q2 2025.
  • BioNTech SE's Revenue's 5-year high stood at $7.2 billion during Q3 2021, with a 5-year trough of $138.6 million in Q2 2024.
  • Its 5-year average for Revenue is $2.6 billion, with a median of $1.6 billion in 2023.
  • Over the last 5 years, BioNTech SE's Revenue had its largest YoY gain of 1379780.34% in 2021, and its largest YoY loss of 9999.85% in 2021.
  • BioNTech SE's Revenue (Quarter) stood at $6.3 billion in 2021, then plummeted by 31.03% to $4.4 billion in 2022, then plummeted by 63.54% to $1.6 billion in 2023, then decreased by 20.09% to $1.3 billion in 2024, then surged by 39.64% to $1.8 billion in 2025.
  • Its last three reported values are $1.8 billion in Q3 2025, $295.2 million for Q2 2025, and $192.3 million during Q1 2025.